7 completed, 5 recruiting, 3 active not recruiting, 3 unknown. 6 Phase 2, 2 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Active not recruiting 2, Completed 2, Enrolling by invitation 2 |
| Not applicable | 2 | Active not recruiting 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Pseudohypoparathyroidism: new trials by email Literature Review of Pseudohypoparathyroidism trials Research Report on Pseudohypoparathyroidism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a) Setmelanotide - Pseudohypoparathyroidism Type 1a, Obesity | Phase 2 | Enrolling by invitation | Massachusetts General Hospital | 1 | 2026-07-21 | 2026-07-23 |
| Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism Hypoparathyroidism, Pseudo Hypoparathyroidism | Not yet recruiting | Dacima Consulting | 1000 | 2025-02-27 | 2025-02-21 | |
| Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism Hypoparathyroidism, Pseudo Hypoparathyroidism | Recruiting | F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore | 600 | 2024-11-04 | 2025-01-23 | |
| Natural History Study of Parathyroid Disorders Parathyroid Cancer, Primary Hyperparathyroidism | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3000 | 2021-11-30 | 2026-09-17 | |
| German Hypoparathyroidism Registry Hypoparathyroidism, Pseudohypoparathyroidism | Recruiting | University Hospital Augsburg | 150 | 2021-07-06 | 2026-10-05 | |
| Determination of Circulating Autotaxin in Patients With GNAS or PTH Abnormalities blood sample - Fibrous Dysplasia, Albright Syndrome | Completed | Hospices Civils de Lyon | 33 | 2021-03-10 | 2023-03-24 | |
| Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old Theophylline, Placebo - Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy | Phase 2 | Active not recruiting | Vanderbilt University Medical Center | 34 | 2020-07-13 | 2026-04-29 |
| Theophylline for Treatment of Pseudohypoparathyroidism Theophylline ER - Pseudohypoparathyroidism, Pseudohypoparathyroidism Type 1a | Phase 2 | Enrolling by invitation | Jaclyn Tamaroff | 34 | 2020-05-22 | 2026-09-02 |
| Effect of Theophylline in Pseudohypoparathyroidism Theophylline - PHP Ia, PHP IB | Phase 4 | Recruiting | Massachusetts General Hospital | 100 | 2019-11-11 | 2022-07-22 |
| QoL and Cognitive Function in Patients With Hypoparathyroidism MRI scans, Neuro cognitive tests, Questionnaires on Quality of Life - Hypoparathyroidism, Pseudo Hypoparathyroidism | Completed | University of Aarhus | 64 | 2019-10-01 | 2021-12-23 | |
| Glucose Homeostasis in Pseudohypoparathyroidism Pseudohypoparathyroidism and Pseudopseudohypoparathyroidism, Pseudohypoparathyroidism Type Ia | Terminated | Vanderbilt University Medical Center | 14 | 2019-06-19 | 2026-05-04 | |
| Theophylline Treatment for Pseudohypoparathyroidism Theophylline, Placebos - Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy | Phase 2 | Active not recruiting | Vanderbilt University Medical Center | 29 | 2018-09-01 | 2026-09-02 |
| IDMet (RaDiCo Cohort) (RaDiCo-IDMet) Silver Russell Syndrome, Beckwith-Wiedemann Syndrome | Recruiting | Institut National de la Santé Et de la Recherche Médicale, France | 2000 | 2017-03-10 | 2026-02-12 | |
| Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy) Theophylline - Pseudohypoparathyroidism Type 1a, Albright Hereditary Osteodystrophy | Phase 2 | Completed | Vanderbilt University Medical Center | 6 | 2015-06-01 | 2017-06-26 |
| Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy | Completed | Vanderbilt University Medical Center | 39 | 2014-12-01 | 2019-11-13 | |
| Characterization of Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism Idiopathic Hypoparathyroidism, Autosomal Dominant Hypocalcaemia | Unknown | University of Aarhus | 100 | 2014-06-01 | 2018-08-07 | |
| Clinical Study for Development of Oral Galactose Single Point (OGSP) Solution (G.S.P. Oral Solution®) G.S.P. Oral Solution 400 mg/ml - Galactose Single Point (GSP), Residual Liver Function | Phase 3 | Unknown | Richever Enterprise Co., Ltd. | 200 | 2013-09-09 | 2018-03-07 |
| Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a Pseudohypoparathyroidism Type 1A, Albright Hereditary Osteodystrophy | Terminated | Children's Hospital of Philadelphia | 519 | 2011-06-01 | 2018-08-22 | |
| GSP as an Novel Indicator for Residual Liver Function in Patients With Fatty Liver Drug: G.S.P. Solution 400 mg/ml I.V. 1.25 ml/kg BW G.S.P. solution after fasting for 6 hours. - Galactose Single Point (GSP), Residual Liver Function | Phase 1 / Phase 2 | Completed | National Defense Medical Center, Taiwan | 210 | 2007-07-05 | 2020-09-14 |
| Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments Neurocognitive and psychosocial testing - Pseudohypoparathyroidism Type 1A, Albright Hereditary Osteodystrophy | Not applicable | Active not recruiting | Connecticut Children's Medical Center | 600 | 2003-01-01 | 2026-06-02 |
Showing 20 of 23. Sign in to see all of them.
Hypoparathyroidism (6) · Dwarfism, Pituitary (2) · Hyperparathyroidism (2) · Pseudopseudohypoparathyroidism (2) · Angelman Syndrome (1) · Beckwith-Wiedemann Syndrome (1) · Behavior (1) · Cognitive Dysfunction (1) · Endocrine System Diseases (1) · Fibrous Dysplasia of Bone (1) · Fibrous Dysplasia, Polyostotic (1) · Hypercalciuric Hypocalcemia, Familial (1) · Hyperparathyroidism, Primary (1) · Hypocalcemia (1)
Bone Diseases (23) · Bone Diseases, Metabolic (23) · Calcium Metabolism Disorders (23) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (23) · Genetic Diseases, Inborn (23) · Metabolic Diseases (23) · Metabolism, Inborn Errors (23) · Metal Metabolism, Inborn Errors (23) · Musculoskeletal Diseases (23) · Nutritional and Metabolic Diseases (23) · Endocrine System Diseases (10) · Parathyroid Diseases (7) · Nutrition Disorders (4) · Bone Diseases, Developmental (3) · Central Nervous System Diseases (3)
Theophylline (4) · Blood Specimen Collection (2) · Magnetic Resonance Imaging (1) · setmelanotide (1)
Vanderbilt University Medical Center (5) · Massachusetts General Hospital (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · University of Aarhus (2) · Children's Hospital of Philadelphia (1) · Connecticut Children's Medical Center (1) · Dacima Consulting (1) · F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore (1) · Hospices Civils de Lyon (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · Jaclyn Tamaroff (1) · National Center for Research Resources (NCRR) (1) · National Defense Medical Center, Taiwan (1) · Richever Enterprise Co., Ltd. (1) · University Hospital Augsburg (1)
United States (12) · Denmark (2) · France (2) · Italy (2) · Germany (1) · Tunisia (1)
Jaclyn Tamaroff, MD (3) · Ashley H Shoemaker, MD (1) · Ashley H Shoemaker, MD, MSCI (1) · Ashley Shoemaker, MD (1) · Emily L Germain-Lee, MD (1) · Lars Rejnmark, DmSci, PhD (1) · Lee S Weinstein, M.D. (1) · Michael A Levine, M.D. (1) · Mitchell E. Geffner (1) · Nabila Rekik Mejdoub, MD (1) · Paolo Beck-Peccoz, MD/PhD (1) · Smita Jha, M.D. (1)
PMID 16675931, PMID 17164301, PMID 17652219, PMID 18252944, PMID 20610593, PMID 20719837, PMID 21525160, PMID 24030943, PMID 25894639, PMID 26709970, PMID 29059381, PMID 31145125, PMID 35079678, PMID 35226254, PMID 36662765, PMID 37284613, PMID 37288292, PMID 37339334, PMID 38174154, PMID 39946193, PMID 40709359, PMID 41763924, PMID 42484783, PMID 42620272
K23DK101689 (1), R21HD078864 (1)